New drug combo trial offers hope for advanced colon cancer patients
NCT ID NCT07309289
Summary
This study compares two different chemotherapy combinations for people newly diagnosed with advanced colorectal cancer that has spread. Researchers want to see if a newer combination called NALIRIFOX works better and is safer than the standard FOLFOX treatment, when both are given with targeted therapy drugs. The trial will involve 144 patients across multiple hospitals to measure how long the cancer stays controlled and how patients respond.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER (CRC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai Zhongshan Hospital
RECRUITINGShanghai, China
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.